New Year, New Home for Serious Skincare at Evine
MINNEAPOLIS, Jan. 02, 2019 (GLOBE NEWSWIRE) — Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform interactive video and digital commerce company (evine.com), today […]
Allscripts closes previously announced sale of its interests in Netsmart
CHICAGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Allscripts (NASDAQ: MDRX) closed the previously announced sale of its interests in Netsmart […]
Restoration Robotics® Secures ISO 13485:2016 Certification
Announces Shipment of first ARTAS iX™ Systems to Europe SAN JOSE, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — Restoration Robotics, […]
Biome Announces OTCQB Listing
Biome Announces Upgraded US Listing to OTCQB Venture Market TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (“Biome” […]
The Scotts Miracle-Gro Foundation Launches Grassroots Grants with KidsGardening to Bring Garden Benefits to More Children
Annual grant program will increase youth garden development nationwide MARYSVILLE, Ohio, Jan. 02, 2019 (GLOBE NEWSWIRE) — Today, The Scotts […]
Eidos Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a […]
Merus Announces Strategic Collaboration with Betta Pharmaceuticals to Develop and Commercialize MCLA-129 in China
Merus to retain all global rights outside of ChinaBetta Pharmaceuticals to fund global IND-enabling activities UTRECHT, the Netherlands, Jan. 02, […]
Mersana Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
Sarepta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare […]
Jounce Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the […]
